Physicians rely on the latest, high-quality evidence to tailor patient care. However, accessing such data can be challenging, necessitating high-quality, reliable, transparent, unbiased, and updated information. Nucleati utilizes cutting-edge technologies to collect, curate, store, and distribute such medical evidence using fully automated workflows.
Among our innovative products are:
Adenine AI: AI collected, curated, and updated evidence to assist medical geneticists, molecular pathologists, genetic counselors, and researchers.
Nucleati Abstracts: Featuring low latency REST-APIs granting access to over 30 million abstracts from published articles, ideal for language processing tasks.
Adverse Drug Reactions Evidence Base: Providing over 35,000 pieces of evidence on adverse effects induced by drugs, drug-drug interactions, and individual genotypes.
Company Details
- Employees
- 2
- Address
- 3903 Bellaire Blvd,
- Industry
- Software Development
- NAICS
-
Software Publishers
- Website
- https://nucleati.com
- Keywords
- São Paulo.
- HQ
- Houston, Texas
Nucleati Questions
Nucleati's website is https://nucleati.com
Nucleati's LinkedIn profile is https://www.linkedin.com/company/nucleati
Nucleati has
2 employees.
View email and phone details for 2
employees at Nucleati.
Nucleati's industry is
Software Development
Nucleati's top competitors are
M Tech Marketer,
Melax Tech, Now Part Of Imo,
Care Express,
Núclea,
The Friedkin Group,
Blueline Ventures,
Hellocare.ai,
Cure Capital Advisors,
Clinicall Limited,
Genialis.
Nucleati's categories are Software Development
